Skip to main content

Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (172)

Clear all filters
Clear all filters

Elsubrutinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (Lymphoma/CLL)

Drug Class / Mechanism

BTK Inhibitor

Eltanexor

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (Multiple Myeloma/DLBCL)

Drug Class / Mechanism

XPO1 (Exportin-1) Inhibitor

Entinostat

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (Lymphoma)

Drug Class / Mechanism

HDAC Inhibitor

Entospletinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic

Drug Class / Mechanism

SYK / Multi-Kinase Inhibitor

Enzomenib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic

Drug Class / Mechanism

EZH2 / Menin Inhibitor

Equecabtagene Autoleucel

Cellular Therapy (CAR-T)

Therapeutic Category

Cellular Therapy (CAR-T)

Oncology Type

Hematologic (Leukemia/Lymphoma/Myeloma)

Drug Class / Mechanism

Chimeric Antigen Receptor T-Cell Therapy

Fedratinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (MPN)

Drug Class / Mechanism

JAK Inhibitor

Flumatinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (Leukemia)

Drug Class / Mechanism

BCR-ABL Tyrosine Kinase Inhibitor

Fostamatinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic

Drug Class / Mechanism

SYK / Multi-Kinase Inhibitor

Gandotinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (MPN)

Drug Class / Mechanism

JAK Inhibitor

Gemtuzumab Ozogamicin

Targeted Therapy (Antibody-Drug Conjugate)

Therapeutic Category

Targeted Therapy (Antibody-Drug Conjugate)

Oncology Type

Hematologic

Drug Class / Mechanism

ADC

Gilteritinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (AML)

Drug Class / Mechanism

FLT3 Inhibitor